To further investigate whether the anti-NAFLD effect of CP is PPARα-dependent, we constructed whole-body Pparα knockout (Pparα−/−) mice (Fig. S2). This evidence concerns the gene CP and metabolic dysfunction-associated steatotic liver disease.